Al-Nimri M - Search Results

1

Electrophysiologic effects of adenosine in patients with supraventricular tachycardia.

Glatter KA, Cheng J, Dorostkar P, Modin G, Talwar S, Al-Nimri M, Lee RJ, Saxon LA, Lesh MD, Scheinman MM. Glatter KA, et al. Among authors: al nimri m. Circulation. 1999 Mar 2;99(8):1034-40. doi: 10.1161/01.cir.99.8.1034. Circulation. 1999. PMID: 10051297

2

Angioplasty vs stent in the treatment of transplant renal artery stenosis.

Chen LX, De Mattos A, Bang H, Vu CT, Gandhi M, Alnimri M, Gallay B, Fananapazir G. Chen LX, et al. Clin Transplant. 2018 Apr;32(4):e13217. doi: 10.1111/ctr.13217. Epub 2018 Feb 28. Clin Transplant. 2018. PMID: 29394514

3

Tonsillar Kaposi sarcoma in a renal transplant patient.

Howard JH 3rd, Darrow M, Chen LX, Alnimri M, Jen KY. Howard JH 3rd, et al. Transpl Infect Dis. 2020 Oct;22(5):e13347. doi: 10.1111/tid.13347. Epub 2020 Jun 16. Transpl Infect Dis. 2020. PMID: 32495980

4

COVID-19 Manifesting as Renal Allograft Dysfunction, Acute Pancreatitis, and Thrombotic Microangiopathy: A Case Report.

Jespersen Nizamic T, Huang Y, Alnimri M, Cheng M, Chen LX, Jen KY. Jespersen Nizamic T, et al. Transplant Proc. 2021 May;53(4):1211-1214. doi: 10.1016/j.transproceed.2020.10.048. Epub 2020 Dec 18. Transplant Proc. 2021. PMID: 33436168 Free PMC article.

5

Low-dose rabbit antithymocyte globulin versus basiliximab induction therapy in low-risk renal transplant recipients: 8-year follow-up.

Laftavi MR, Alnimri M, Weber-Shrikant E, Kohli R, Said M, Patel S, Pankewycz O. Laftavi MR, et al. Transplant Proc. 2011 Mar;43(2):458-61. doi: 10.1016/j.transproceed.2011.01.035. Transplant Proc. 2011. PMID: 21440733

6

Mycophenolic acid dose reductions result in poor long-term renal allograft survival: comparison between mycophenolate sodium and mycophenolate mofetil.

Laftavi MR, Hai F, Laftavi H, Feng L, Said M, Patel S, Kohli R, Alnimri M, Dayton M, Pankewycz O. Laftavi MR, et al. Transplant Proc. 2011 Mar;43(2):478-81. doi: 10.1016/j.transproceed.2011.01.037. Transplant Proc. 2011. PMID: 21440738

7

Low-dose thymoglobulin use in elderly renal transplant recipients is safe and effective induction therapy.

Laftavi MR, Patel S, Soliman MR, Alnimri M, Kohli R, Said M, Pankewycz O. Laftavi MR, et al. Transplant Proc. 2011 Mar;43(2):466-8. doi: 10.1016/j.transproceed.2011.01.039. Transplant Proc. 2011. PMID: 21440735

8

Obesity in renal transplantation: the role of induction therapy on long-term outcomes.

Patel S, Pankewycz O, Kohli R, Said M, Alnimri M, Feng L, Laftavi MR. Patel S, et al. Transplant Proc. 2011 Mar;43(2):469-71. doi: 10.1016/j.transproceed.2011.01.040. Transplant Proc. 2011. PMID: 21440736

9

African-American women and older patients are at risk for a greater decline in renal function following living kidney donation.

Alnimri M, Laftavi MR, Kohli R, Said M, Feng L, Patel S, Pankewycz O. Alnimri M, et al. Transplant Proc. 2011 Mar;43(2):512-5. doi: 10.1016/j.transproceed.2011.01.041. Transplant Proc. 2011. PMID: 21440747

10

Conversion to low-dose tacrolimus or rapamycin 3 months after kidney transplantation: a prospective, protocol biopsy-guided study.

Pankewycz O, Leca N, Kohli R, Weber-Shrikant E, Said M, Alnimri M, Feng L, Patel S, Laftavi MR. Pankewycz O, et al. Transplant Proc. 2011 Mar;43(2):519-23. doi: 10.1016/j.transproceed.2011.01.033. Transplant Proc. 2011. PMID: 21440749 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters